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ABSTRACT Background
Sympathetic activation in heart failure patients favors the development of ventricular arrhythmias, thus leading to an increased risk of sudden cardiac death. 1 and 2 30 adrenergic receptor polymorphisms have been linked to the risk of sudden death.
Implantable cardioverter-defibrillators (ICD) are implanted in a large percentage of heart failure patients, and beyond preventing sudden cardiac death they provide a continuous monitoring of major ventricular arrhythmias and of their own interventions. We investigated whether functionally relevant 1 and 2-adrenergic Methods 311 patients with systolic heart failure were enrolled, and number and timing of shocks 40 in ICD memory were recorded.
Four selected polymorphisms were determined: 1 adrenergic receptor polymorphisms Ser 49 Gly and Arg 389 Gly and 2 adrenergic receptor polymorphisms Arg 16 Gly and Gln 27 Glu.
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Results
Only Ser 49 Gly was significantly correlated with time free from ICD shocks, both considering time to the first event in a Cox model (hazard ratio 2.117), and modeling repeated events with the Andersen-Gill method (hazard ratio 2.088). Gly allele
Introduction
In heart failure (HF) patients with reduced ejection fraction (EF), sympathetic activation, mediated by the 1-adrenergic and 2-adrenergic receptors, favors the 60 development of ventricular arrhythmias, thus leading to an increased risk of sudden cardiac death. Implantable cardioverter-defibrillator (ICD) is therefore indicated in a large percentage of HF patients; beyond preventing sudden cardiac death, ICD provides a continuous monitoring of major ventricular arrhythmias and of its own interventions. ICD shocks represent an event with the peculiar characteristic that it 65 can repeat several times.
In the present study, in order to assess the role of functionally relevant 1 and 2 adrenergic receptor polymorphisms, we investigated whether they are associated with the risk of ICD shocks.
Two 1-adrenergic receptor functionally relevant single nucleotide 70 polymorphisms (SNPs) have been identified, with amino acid substitutions Arg 389 Gly (1) and Ser 49 Gly, and widely studied, associated with better prognosis in patients with HF in some, but not all, studies.
For the 2-adrenergic receptor thirteen SNPs have been described; two common SNPs result in the amino acid substitutions Gly 16 Arg and Gln 27 Glu. There are only a 75 few reports suggesting a prognostic effect of these polymorphisms, both in general population (2) and in HF patients (3, 4) , while there are not studies on their effect on ventricular arrhythmias.
The role of these four polymorphisms was investigated in the present study in 311 patients with HF, implanted with an ICD according to current guidelines (5).
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Methods
Study population
Consecutive eligible patients were enrolled from the HF outpatient clinic of two 85 Hospitals (Verona and Mantova). Diagnosis of heart failure with reduced EF was based on criteria defined by European guidelines (5).
Eligibility criteria required that patients had to be implanted with ICD at least one month before, either for primary or for secondary prevention, according to current guidelines. Further eligibility criteria were age >18 years and reduced left ventricular Patients were followed by the outpatient HF clinic of the two Hospitals. All patients had to be on optimal medical therapy on enrolment, according to European guidelines (5).
The study was approved by the Institutional Review Board of both participating hospitals; it was conducted in accordance with the Helsinki Declaration, and all 105 patients provided written informed consent. Therapies delivered to treat rhythm other than ventricular tachyarrhythmias (e.g. atrial fibrillation) were considered inappropriate. Only appropriate therapies were 135 included in the analysis. It was recorded also if the ICD intervention took place during an electrical storm, defined as the occurrence of 3 or more shocks during a single 24-h period (6) .
Demographic and clinical data
The choice to include in the analysis only shocks and to exclude arrhythmias terminated by fast pacing, i.e. ATP, was based on considering that the time interval 140 during which our data were collected was wide, and in the first years ATP was used mainly to treat slower tachycardias, with heart rate below 190-200; however, these arrhythmias do not always cause or proceed to cardiac arrest and cannot thus be considered a surrogate variable for fatal arrhythmias. Shock programming, on the contrary, was more homogenously applied over time in faster, not electrically 145 organized arrhythmias, which are easily interpreted as a surrogate of sudden cardiac death (7,8).
Sample preparation and DNA Genotyping
Blood samples were collected in ethylenediaminetetraacetic acid (EDTA) and 150 stored frozen at -80° C prior to DNA extraction. Genomic DNA was extracted from whole blood by an automated "on-column" DNA purification method on a QIAsymphony SP instrument (QIAGEN GmbH, Germany), according to manufacturer's protocols. DNA quality and concentration was assessed on a NanoDrop 8000 spectrometer (ThermoScientific Inc.). A 5' nuclease assay with MGB 
Results
Study population
A total of 311 patients were enrolled in the study. Demographics are reported in Table 1 .
All patients were Caucasians, born in Italy. Male subjects were 263 (84.6%) and 185 the average age was 64.2±10.6 years. The etiology was ischemic in 188 patients (60.5%). Sinus rhythm was observed in 221 patients (71.1%). The ICD had been implanted in primary prevention in 244 patients (78.5%); biventricular stimulation was applied in 210 patients (67.5%). Median beta-blocker dosage on enrolment was 50% (interquartile range 37.5-100). 
Beta adrenergic receptor polymorphisms
The genotype frequencies of the different polymorphisms are presented in Table   2 .
The genotype frequencies were in agreement with those predicted by the 205 Hardy-Weinberg equilibrium.
Beta adrenergic receptor polymorphisms and ICD shocks
The univariate relationship at the Cox model between time free from ICD shock and genetic polymorphisms is reported in Table 3 . The relationship at the Cox model 210 between time free from shock and homozygotes for the reference allele vs. carriers of the variant allele is reported in Table 4 .
The analysis was then performed using the Andersen-Gill method, by which all events are kept into account. The results for ICD shock occurrence according to genetic polymorphism are reported in Table 5 .
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The influence of clinically relevant covariates was also assessed with the Andersen-Gill method: no effect was evident for gender, age, ICD indication (primary When including in a multivariate model the β1 Ser 49 Gly polymorphism, the only one related with ICD shock at univariate analysis, and the two significant covariates 225 (namely beta-blocker dosage and ejection fraction), all of them maintained the statistical significance (Table 6 ), thus proving their independent predicting value.
An additional sensitivity analysis was conducted: the analysis for repeated ICD shocks was performed excluding ICD storms, in order to avoid an excessive influence of patients with several ICD shocks. Nevertheless, the significance of the effect of β1
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Ser 49 Gly remained, and it was further increased (HR 2.892; c.i. 1.631 -5.129; p=0.0001].
Discussion
Current guidelines (5) recommend ICD implantation for a significant proportion 235 of the heart failure patients. It is however well known that, particularly in primary prevention, the proposed criteria have a low specificity. Even in our series, over a median 49 month period, 75% of the patients did not experience any ICD shock.
Identifying new markers of arrhythmic risk could possibly improve risk stratification and ICD usage. Even potentially more interesting, on the opposite side, could be the 
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ICD shock could be considered as a surrogate for fatal arrhythmias and thus for sudden cardiac death, the latter being almost always caused by an arrhythmic event.
Although this concept has been questioned, mainly for the observation that a reduction in ICD shock is not associated with an improvement in survival (17) , one could expect in any case a lower number of ICD shocks to be linked with a better 295 prognosis and better quality of life (11).
The Gly49 allele, however, was associated in previous studies with a better prognosis, and this observation could indirectly conflict with our results. The most frequently quoted studies are two papers published by a Swedish group (18, 19) ; these studies, however, enroll also patients with preserved ejection fraction, which have a 300 different natural history; moreover in the first cohort (17) only 40% of the patients were on beta blockers. In the second cohort (18) with 83% of the patients on beta blockers, the five year transplant-free survival did not differ between Ser 49 homozygotes patients and Gly49 allele carriers.
The only other study to report a significant effect of Ser 49 Gly polymorphism is the In another study on HF patients (3), the presence of the Arg16 allele and the homozigosity Gln 27 Gln were associated with a better prognosis in patients with 350 idiopathic dilated cardiomyopathy, but only the simultaneous presence of two copies of Arg16 Gln27 was associated with a worse prognosis in another study (4) , in patients with HF of all etiologies. However, no prognostic effect in HF patients was found in other studies (19, 20, 21) . We were not able to identify any effect of these 2-adrenergic receptor polymorphism.
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Conclusions
In conclusion, data from our study suggest that the Gly 49 allele of the 1-adrenergic receptor Ser 49 Gly polymorphisms may identify patients with heart failure at increased risk of ICD shock and thus of life-threatening arrhythmias.
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The main drawback of the current study is the limited number of patients; the hypothesis ought to be verified in a larger study, which could also assess the role of gene haplotypes.
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